AAAAAA

   
Results: 1-25 |
Results: 25

Authors: Simonart, T Degraef, C Stordeur, P Noel, JC Mosselmans, R Van Vooren, JP Parent, D Boelaert, JR Heenen, M Galand, P
Citation: T. Simonart et al., Iron induces Bcl-2 expression in human dermal microvascular endothelial cells, FREE RAD RE, 34(3), 2001, pp. 221

Authors: Simonart, T Simonart, JM Derdelinckx, I De Dobbeleer, G Verleysen, A Verraes, S de Maubeuge, J Van Vooren, JP Naeyaert, JM de la Brassine, M Peetermans, WE Heenen, M
Citation: T. Simonart et al., Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis, CLIN INF D, 32(1), 2001, pp. E9-E12

Authors: Englert, Y Van Vooren, JP Place, I Liesnard, C Laruelle, C Delbaere, A
Citation: Y. Englert et al., ART in HIV-infected couples - Has the time come for a change of attitude?, HUM REPR, 16(7), 2001, pp. 1309-1315

Authors: Simonart, T Boelaert, JR Van Vooren, JP Heenen, M
Citation: T. Simonart et al., Iron and Kaposi's sarcoma, ANN DER VEN, 128(5), 2001, pp. 659-661

Authors: Simonart, T Degraef, C Mosselmans, R Hermans, P Lunardi-Iskandar, Y Noel, JC Van Vooren, JP Parent, D Heenen, M Galand, P
Citation: T. Simonart et al., Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis, J INVES DER, 116(5), 2001, pp. 679-685

Authors: Tanghe, A Content, J Van Vooren, JP Portaels, F Huygen, K
Citation: A. Tanghe et al., Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer, INFEC IMMUN, 69(9), 2001, pp. 5403-5411

Authors: Simonart, T Van Vooren, JP Parent, D Heenen, M Boelaert, JR
Citation: T. Simonart et al., Role of iron in dermatology, DERMATOLOGY, 200(2), 2000, pp. 156-159

Authors: Dieye, TN Van Vooren, JP Delforge, ML Liesnard, C Devleeschouwer, M Farber, CM
Citation: Tn. Dieye et al., Spontaneous apoptosis and highly active antiretroviral therapy (HAART), BIOMED PHAR, 54(1), 2000, pp. 16-20

Authors: Zlotta, AR Van Vooren, JP Huygen, K Drowart, A Decock, M Pirson, M Jurion, F Palfliet, K Denis, O Simon, J Schulman, CC
Citation: Ar. Zlotta et al., What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?, EUR UROL, 37(4), 2000, pp. 470-477

Authors: Simonart, T Van Vooren, JP
Citation: T. Simonart et Jp. Van Vooren, Long latency of human herpesvirus type 8 infection and the appearance of classic Kaposi's sarcoma - Reply, J AM ACAD D, 43(4), 2000, pp. 732-732

Authors: Simonart, T Van Vooren, JP Meuris, S
Citation: T. Simonart et al., Kaposi's sarcoma, N ENG J MED, 343(8), 2000, pp. 582-582

Authors: Simonart, T Degraef, C Andrei, G Mosselmans, R Hermans, P Van Vooren, JP Noel, JC Boelaert, JR Snoeck, R Heenen, M
Citation: T. Simonart et al., Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors, J INVES DER, 115(5), 2000, pp. 893-900

Authors: Zlotta, AR Van Vooren, JP Denis, O Drowart, A Daffe, M Lefevre, P Schandene, L De Cock, M De Bruyn, J Vandenbussche, P Jurion, F Palfliet, K Simon, J Schulman, CC Content, J Huygen, K
Citation: Ar. Zlotta et al., What are the immunologically active components of Bacille Calmette-Guerin in therapy of superficial bladder cancer?, INT J CANC, 87(6), 2000, pp. 844-852

Authors: Simonart, T Hermans, P Schandene, L Van Vooren, JP
Citation: T. Simonart et al., Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature, BR J DERM, 143(3), 2000, pp. 557-563

Authors: Steinfeld, SD Demols, P Van Vooren, JP Cogan, E Appelboom, T
Citation: Sd. Steinfeld et al., Zidovudine in primary Sjogren's syndrome, RHEUMATOLOG, 38(9), 1999, pp. 814-817

Authors: Simonart, T De Dobbeleer, GR Peny, MO Fayt, I Parent, D Van Vooren, JP Noel, JC
Citation: T. Simonart et al., Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions, EUR J DERM, 9(6), 1999, pp. 480-482

Authors: Delforge, ML Farber, CM De Leener, F Caroyer, JM Liesnard, C Van Vooren, JP
Citation: Ml. Delforge et al., Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system, CLIN INF D, 28(4), 1999, pp. 931-931

Authors: Simonart, T Andrei, G Parent, D Van Vooren, JP De Clercq, E Snoeck, R
Citation: T. Simonart et al., In vitro sensitivity of Kaposi's sarcoma cells to various chemotherapeuticagents including acyclic nucleoside phosphonates, ANTIVIR CHE, 10(3), 1999, pp. 129-134

Authors: Simonart, T Dargent, JL Hermans, P Fayt, I Hawaux, E Van Vooren, JP Noel, JC
Citation: T. Simonart et al., Penile intraepithelial neoplasia overlying Kaposi's sarcoma lesions - Roleof viral synergy?, AM J DERMAT, 21(5), 1999, pp. 494-497

Authors: De Thier, F Simonart, T Hermans, P Andre, J Van Vooren, JP Noel, JC
Citation: F. De Thier et al., Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction, AM J DERMAT, 21(1), 1999, pp. 25-27

Authors: Simonart, T Noel, JC Van Vooren, JP De Dobbeleer, G
Citation: T. Simonart et al., Classic Kaposi's sarcoma after multiple-partner heterosexual behavior in Central Africa, J AM ACAD D, 41(4), 1999, pp. 648-649

Authors: Zlotta, AR Noel, JC Fayt, I Drowart, A Van Vooren, JP Huygen, K Simon, J Schulman, CC
Citation: Ar. Zlotta et al., Correlation and prognostic significance of p53, A21(WAF1/CIP1) and Ki-67 expression in patients with superficial bladder tumors treated with bacillusCalmette-Guerin intravesical therapy, J UROL, 161(3), 1999, pp. 792-798

Authors: Simonart, T Van Vooren, JP Herbauts, J Boelaert, JR
Citation: T. Simonart et al., Nigh incidence of Kaposi's sarcoma in Iceland and the Faroe Islands, BR J CANC, 79(2), 1999, pp. 373-373

Authors: Simonart, T Hermans, P Van Vooren, JP Meuris, S
Citation: T. Simonart et al., Paradoxical pro-Kaposi's sarcoma activity of preparations of human chorionic gonadotropin, BLOOD, 94(1), 1999, pp. 376-377

Authors: Colardijn, F Damas, P De Mol, P Glupczynski, Y Gordus, B Ronveaux, O Struelens, M Thys, JP Verhaegen, J Vogelaers, D Wilmotte, L Bossens, M Byl, B Carpentier, M Claeys, G Crokaert, F Daux, J Dediste, A De Jongh, D Delporte, JP Desmet, F d'Hollander, A Ezzedine, H Fameree, D Garrino, M Goossens, H Govaerts, D Hecq, JD Ieven, G Jacobs, F Jordens, P Larbuisson, W Laterre, PF Lauwers, S Lefebure, B Lievin, V Meert, P Melin, P Mertens, A Moulin, D Peetermans, W Peleman, R Potvliege, C Reynaert, M Rost, F Simon, A Sion, JP Stuyck, J Valcke, Y Van Beek, F Vandercam, B Van Laethem, Y Van Landuyt, H Van Vooren, JP Van Wyngaarden, E Verbist, L Verschraegen, G Vincent, JL Wauters, G Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16
Risultati: 1-25 |